chr17-50346170-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_022167.4(XYLT2):c.30G>T(p.Leu10=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00807 in 1,286,504 control chromosomes in the GnomAD database, including 769 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.043 ( 480 hom., cov: 32)
Exomes 𝑓: 0.0035 ( 289 hom. )
Consequence
XYLT2
NM_022167.4 synonymous
NM_022167.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.45
Genes affected
XYLT2 (HGNC:15517): (xylosyltransferase 2) The protein encoded by this gene is an isoform of xylosyltransferase, which belongs to a family of glycosyltransferases. This enzyme transfers xylose from UDP-xylose to specific serine residues of the core protein and initiates the biosynthesis of glycosaminoglycan chains in proteoglycans including chondroitin sulfate, heparan sulfate, heparin and dermatan sulfate. The enzyme activity, which is increased in scleroderma patients, is a diagnostic marker for the determination of sclerotic activity in systemic sclerosis. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.47).
BP6
Variant 17-50346170-G-T is Benign according to our data. Variant chr17-50346170-G-T is described in ClinVar as [Benign]. Clinvar id is 1277109.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.45 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.145 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
XYLT2 | NM_022167.4 | c.30G>T | p.Leu10= | synonymous_variant | 1/11 | ENST00000017003.7 | |
XYLT2 | NR_110010.2 | n.45G>T | non_coding_transcript_exon_variant | 1/10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
XYLT2 | ENST00000017003.7 | c.30G>T | p.Leu10= | synonymous_variant | 1/11 | 1 | NM_022167.4 | P1 | |
XYLT2 | ENST00000376550.7 | c.30G>T | p.Leu10= | synonymous_variant, NMD_transcript_variant | 1/10 | 1 | |||
XYLT2 | ENST00000507602.5 | c.30G>T | p.Leu10= | synonymous_variant | 1/10 | 2 | |||
XYLT2 | ENST00000509778.1 | c.30G>T | p.Leu10= | synonymous_variant | 1/2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0433 AC: 6410AN: 147942Hom.: 482 Cov.: 32
GnomAD3 genomes
AF:
AC:
6410
AN:
147942
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00521 AC: 437AN: 83880Hom.: 27 AF XY: 0.00326 AC XY: 154AN XY: 47190
GnomAD3 exomes
AF:
AC:
437
AN:
83880
Hom.:
AF XY:
AC XY:
154
AN XY:
47190
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00348 AC: 3965AN: 1138454Hom.: 289 Cov.: 30 AF XY: 0.00301 AC XY: 1689AN XY: 560850
GnomAD4 exome
AF:
AC:
3965
AN:
1138454
Hom.:
Cov.:
30
AF XY:
AC XY:
1689
AN XY:
560850
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0433 AC: 6412AN: 148050Hom.: 480 Cov.: 32 AF XY: 0.0420 AC XY: 3033AN XY: 72166
GnomAD4 genome
AF:
AC:
6412
AN:
148050
Hom.:
Cov.:
32
AF XY:
AC XY:
3033
AN XY:
72166
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 05, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | - - |
Osteogenesis imperfecta Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | Aug 13, 2021 | - - |
Spondylo-ocular syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Dec 05, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at